The cytoprotective and the dark side of Nrf2

Author： Marchan R.   Bolt H.  

Publisher： Springer Publishing Company

ISSN： 0340-5761

Source： Archives of Toxicology, Vol.87, Iss.12, 2013-12, pp. : 2047-2050

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Induction of Cytoprotective Genes Through Nrf2 / Antioxidant Response Element Pathway: A New Therapeutic Approach for the Treatment of Inflammatory Diseases

By  

Current Pharmaceutical Design, Vol. 10, Iss. 8, 2004-03 ,pp. : 879-891

Bentham Science Publishers

Access to resources Recommend Favorite

The Dark Side of Protein Kinase CK2 Inhibition

By  

Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. : 2867-2884

Bentham Science Publishers

Access to resources Recommend Favorite

The dark side of a 'detoxification' mechanism

By Gillam E.M.J.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 1, 2001-01 ,pp. : 11-11

Elsevier

Access to resources Recommend Favorite

Going to the dark side: clinicians, leadership and the Department of Health

By Armitage Mary  

Clinical Medicine, Vol. 8, Iss. 6, 2008-12 ,pp. : 589-591

Royal College Of Physicians

Access to resources Recommend Favorite

Targeting the Nrf2 pathway against cardiovascular disease

By Li Jinqing   Ichikawa Tomonaga   Janicki Joseph S   Cui Taixing  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 785-794

Informa Healthcare

Access to resources Recommend Favorite